QIAGEN N.V.
QGEN
$47.75
-$0.35-0.73%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.07B | 2.04B | 2.00B | 1.98B | 1.97B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.07B | 2.04B | 2.00B | 1.98B | 1.97B |
| Cost of Revenue | 704.80M | 696.84M | 957.26M | 949.01M | 954.94M |
| Gross Profit | 1.37B | 1.34B | 1.05B | 1.03B | 1.01B |
| SG&A Expenses | 571.51M | 569.06M | 563.61M | 564.36M | 568.60M |
| Depreciation & Amortization | 61.37M | 61.81M | 64.62M | 68.14M | 71.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.53B | 1.51B | 1.77B | 1.78B | 1.79B |
| Operating Income | 544.22M | 527.78M | 231.44M | 203.21M | 180.23M |
| Income Before Tax | 506.95M | 488.68M | 138.41M | 121.15M | 114.17M |
| Income Tax Expenses | 101.58M | 115.29M | 44.73M | 37.56M | 21.24M |
| Earnings from Continuing Operations | 405.37 | 373.39 | 93.68 | 83.59 | 92.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 405.37M | 373.39M | 93.68M | 83.59M | 92.93M |
| EBIT | 544.22M | 527.78M | 231.44M | 203.21M | 180.23M |
| EBITDA | 721.13M | 703.71M | 411.29M | 393.48M | 377.81M |
| EPS Basic | 1.86 | 1.72 | 0.42 | 0.38 | 0.42 |
| Normalized Basic EPS | 1.64 | 1.59 | 0.73 | 0.66 | 0.60 |
| EPS Diluted | 1.85 | 1.70 | 0.41 | 0.37 | 0.41 |
| Normalized Diluted EPS | 1.63 | 1.58 | 0.73 | 0.65 | 0.59 |
| Average Basic Shares Outstanding | 869.97M | 869.23M | 868.35M | 867.59M | 867.18M |
| Average Diluted Shares Outstanding | 874.84M | 874.20M | 871.84M | 871.93M | 871.52M |
| Dividend Per Share | 0.25 | 0.25 | 0.25 | -- | -- |
| Payout Ratio | 13.38% | -- | -- | -- | -- |